Sign in

CIK 0001367644 · Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
141902018
Phone
240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
  1. 8-K Event Other events
  2. 10-Q Report Quarterly Report
  3. 8-K Event Results of operations · Regulation FD disclosure
  4. 8-K Event Executive or director change
  5. 144 Insider Sale of Securities
  6. 4 Planned sale Director sold 17,800 shares at $7.09 ($126,202)
  7. 4 Planned sale SVP, Products Business sold 3,000 shares at $6.53 ($19,590)
  8. 144 Insider Sale of Securities
  9. 8-K Event Regulation FD disclosure
  10. 8-K Event Other events
  11. SCHEDULE 13G Stake Statement of Beneficial Ownership
  12. 3 Insider Initial Statement of Ownership
  13. 10-Q Report Quarterly Report
  14. 8-K Event Results of operations · Exit or restructuring costs · Executive or director change · Regulation FD disclosure
  15. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. 4 Planned sale SVP, Products Business sold 3,000 shares at $8.40 ($25,200)
  18. 144 Insider Sale of Securities
  19. 8-K Event Material agreement · Regulation FD disclosure
  20. 4 Shares withheld for taxes SVP, Products Business gave up 694 shares (to pay taxes)

Page 1 of 87 · 1,733 filings